The 5 analysts offering 12-month price forecasts for ABIOMED Inc have a median target of 220.00, with a high estimate of 230.00 and a low estimate of 152.00. The median estimate represents a +5.95% increase from the last price of 207.65.
The current consensus among 9 polled investment analysts is to Buy stock in ABIOMED Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.30
Reporting Date Jul 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.